Avances en immunosupresión en trasplante hepático

Translated title of the contribution: Advances in immunossuppression in liver transplantation

Marco Antonio Olivera-Martínez

Research output: Contribution to journalArticlepeer-review

Abstract

The history of immunosuppression is a long one. From the utilization of steroids and azathioptine in the 50's to the design of humanized molecules that specifically block cell surface receptors. Liver transplantation is one of the procedures that benefit the most with the development of new immunosuppressors and is also one of the reasons to create a new branch in research and clinical practice: transplant medicine. It also set the standards for research in the "immunologic tolerance" field. The cornerstone in the post-liver transplant stage is the utilization of calcineurin inhibitors combined with new anti-metabolites and monoclonal antibodies. All these settings conforms a promising field in the research of new and better immunosuppressing agents.

Translated title of the contributionAdvances in immunossuppression in liver transplantation
Original languageSpanish
Pages (from-to)237-243
Number of pages7
JournalRevista de Investigacion Clinica
Volume57
Issue number2
StatePublished - Mar 2005
Externally publishedYes

Keywords

  • Basiliximab
  • Cyclosporine
  • Daclizumab
  • Everolimus
  • FTY 720
  • Immunosuppressors
  • Mycophenolate mofetil
  • Tacrolimus

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Advances in immunossuppression in liver transplantation'. Together they form a unique fingerprint.

Cite this